86 related articles for article (PubMed ID: 19739126)
1. S179D Prolactin Sensitizes Human PC3 Prostate Cancer Xenografts to Anti-tumor Effects of Well-Tolerated Doses of Calcitriol.
Holland CT; Hsu J; Walker AM
J Cancer Sci Clin Ther; 2020; 4(4):442-456. PubMed ID: 33179012
[TBL] [Abstract][Full Text] [Related]
2. Orchestration of signaling by structural disorder in class 1 cytokine receptors.
Seiffert P; Bugge K; Nygaard M; Haxholm GW; Martinsen JH; Pedersen MN; Arleth L; Boomsma W; Kragelund BB
Cell Commun Signal; 2020 Aug; 18(1):132. PubMed ID: 32831102
[TBL] [Abstract][Full Text] [Related]
3. Prolactin and prolactin receptor expression in cervical intraepithelial neoplasia and cancer.
Ascencio-Cedillo R; López-Pulido EI; Muñoz-Valle JF; Villegas-Sepúlveda N; Del Toro-Arreola S; Estrada-Chávez C; Daneri-Navarro A; Franco-Topete R; Pérez-Montiel D; García-Carrancá A; Pereira-Suárez AL
Pathol Oncol Res; 2015 Apr; 21(2):241-6. PubMed ID: 24990775
[TBL] [Abstract][Full Text] [Related]
4. High expression of prolactin receptor is associated with cell survival in cervical cancer cells.
Lopez-Pulido EI; Muñoz-Valle JF; Del Toro-Arreola S; Jave-Suárez LF; Bueno-Topete MR; Estrada-Chávez C; Pereira-Suárez AL
Cancer Cell Int; 2013 Oct; 13(1):103. PubMed ID: 24148306
[TBL] [Abstract][Full Text] [Related]
5. Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies.
Ginsburg E; Alexander S; Lieber S; Tarplin S; Jenkins L; Pang L; Heger CD; Goldsmith P; Vonderhaar BK
BMC Cancer; 2010 Dec; 10():678. PubMed ID: 21144038
[TBL] [Abstract][Full Text] [Related]
6. A mimic of phosphorylated prolactin inhibits human breast cancer cell proliferation via upregulation of p21 waf1.
Xie W; He Y; Huo D; Huang Y; Wu W
Med Oncol; 2010 Dec; 27(4):1340-5. PubMed ID: 20013077
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of S179D prolactin--from prostate cancer to angioproliferative disorders: the first selective prolactin receptor modulator.
Walker AM
Expert Opin Investig Drugs; 2006 Oct; 15(10):1257-67. PubMed ID: 16989600
[TBL] [Abstract][Full Text] [Related]
8. Prolactin as an autocrine/paracrine growth factor in human cancer.
Ben-Jonathan N; Liby K; McFarland M; Zinger M
Trends Endocrinol Metab; 2002 Aug; 13(6):245-50. PubMed ID: 12128285
[TBL] [Abstract][Full Text] [Related]
9. Long term increased expression of the short form 1b prolactin receptor in PC-3 human prostate cancer cells decreases cell growth and migration, and causes multiple changes in gene expression consistent with reduced invasive capacity.
Huang KT; Walker AM
Prostate; 2010 Jan; 70(1):37-47. PubMed ID: 19739126
[TBL] [Abstract][Full Text] [Related]
10. S179D prolactin increases vitamin D receptor and p21 through up-regulation of short 1b prolactin receptor in human prostate cancer cells.
Wu W; Ginsburg E; Vonderhaar BK; Walker AM
Cancer Res; 2005 Aug; 65(16):7509-15. PubMed ID: 16103106
[TBL] [Abstract][Full Text] [Related]
11. Blockade of estrogen-stimulated proliferation by a constitutively-active prolactin receptor having lower expression in invasive ductal carcinoma.
Huang KT; Tan D; Chen KE; Walker AM
Cancer Lett; 2015 Mar; 358(2):152-160. PubMed ID: 25527452
[TBL] [Abstract][Full Text] [Related]
12. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice.
Xu X; Kreye E; Kuo CB; Walker AM
Cancer Res; 2001 Aug; 61(16):6098-104. PubMed ID: 11507059
[TBL] [Abstract][Full Text] [Related]
13. Unmodified prolactin (PRL) and S179D PRL-initiated bioluminescence resonance energy transfer between homo- and hetero-pairs of long and short human PRL receptors in living human cells.
Tan D; Johnson DA; Wu W; Zeng L; Chen YH; Chen WY; Vonderhaar BK; Walker AM
Mol Endocrinol; 2005 May; 19(5):1291-303. PubMed ID: 15695371
[TBL] [Abstract][Full Text] [Related]
14. S179D prolactin sensitizes human prostate cancer cells such that physiological concentrations of 1, 25 dihydroxy vitamin D3 result in growth inhibition and cell death.
Wu W; Zanello L; Walker AM
Prostate; 2007 Oct; 67(14):1498-506. PubMed ID: 17680631
[TBL] [Abstract][Full Text] [Related]
15. Insensitivity of human prolactin receptors to nonhuman prolactins: relevance for experimental modeling of prolactin receptor-expressing human cells.
Utama FE; Tran TH; Ryder A; LeBaron MJ; Parlow AF; Rui H
Endocrinology; 2009 Apr; 150(4):1782-90. PubMed ID: 19022890
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
